))
Radioactive Iodine: Unraveling the Mystery (Part 2)
Manage episode 472051942 series 3586605
Content provided by TIRO, THANC Foundation, TIRO, and THANC Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TIRO, THANC Foundation, TIRO, and THANC Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In Part 2 of this episode of Voices of Wisdom, Dr. Dana Hartl continues her conversation with Dr. David Pattison, diving deeper into radioactive iodine therapy for thyroid cancer. They discuss the biological mechanisms of I-131, key differences from external beam radiation, and evolving strategies for personalized treatment. Dr. Pattison also explores future advancements, including re-differentiation therapy and the role of nuclear medicine in optimizing patient care.
Feel free to send your questions or suggestions about future episodes to [email protected].
To subscribe to receive info about upcoming TIROxMDS webinars, click here: tiro.expert/subscribe
11 episodes
Share
